A clear trend towards more patients undergoing antileukemic therapy (2005–2011: 19% vs. 2012 and after: 71%) can be observed.
← all excerpts
The Evolution of Treatment Policies and Outcomes for Patients Aged 60 and Older with Acute Myeloid Leukemia: A Population-Based Analysis over Two Decades.
1
—
—